蒙药森登-4汤对p38-MAPK/NF-κB信号通络干预膝关节骨性关节炎的作用机制研究
Study on the Mechanism of Action of Mongolian Medicine Sendeng-4 Decoction in Intervening Knee Osteoarthritis through the p38-MAPK/NF-κB Signaling Pathway
DOI: 10.12677/acm.2025.1541032, PDF,    科研立项经费支持
作者: 白福贵, 布日古德, 白曙明, 苏力德, 金爱华, 色音宝音, 那阿乐木斯, 韩铁龙:内蒙古自治区国际蒙医医院蒙医骨伤科,内蒙古 呼和浩特;乌兰巴特尔*:内蒙古民族大学研究生学院,内蒙古 通辽
关键词: 蒙药森登-4汤膝关节骨性关节炎p38-MAPK/NF-κB信号通络Mongolian Medicine Sendeng-4 Decoction Knee Osteoarthritis p38-MAPK/NF-κB Signaling Pathway
摘要: 文章分析了蒙药森登-4汤对p38-MAPK/NF-κB信号通络干预膝关节骨性关节炎的作用机制。方法:选择2021年01月~2023年12月来医院治疗全膝关节置换术的膝关节骨性关节炎患者60例,随机分成两组,每组30例患者,年龄40~80岁,平均年龄为57岁。治疗组与对照组两组p38-MAPK、NF-κB及其磷酸化、IL-1、IL-6、IL-1β、TNF-α表达情况进行比较。结果:对照组与治疗组相比p38-MAPK、p65-NF-κB及其磷酸化、IL-1、IL-6、IL-1β、TNF-α表达水平都有显著升高, 差异均有统计学意义(P < 0.05)。结论:研究结果说明,蒙药森登-4汤对p38-MAPK/NF-κB信号通络干预膝关节骨性关节炎有显著效果,不良反应少。
Abstract: This paper studies the Mechanism of Action of Mongolian Medicine Sendeng-4 Decoction in Intervening Knee Osteoarthritis through the p38-MAPK/NF-κB Signaling Pathway. Methods: Sixty patients with knee osteoarthritis who underwent total knee arthroplasty in the hospital from January 2021 to December 2023 were selected and randomly divided into two groups, with 30 cases in each group. The age range was 40 to 80 years old, with an average age of 57 years. The expression levels of p38-MAPK, NF-κB and their phosphorylated forms, IL-1, IL-6, IL-1β, and TNF-α were compared between the treatment group and the control group. Results: Compared with the treatment group, the expression levels of p38-MAPK, p65-NF-κB and their phosphorylated forms, IL-1, IL-6, IL-1β, and TNF-α in the control group were significantly increased, and the differences were statistically significant (P < 0.05). Conclusion: The research results indicate that Mongolian Medicine Sendeng-4 Decoction has a significant effect in intervening knee osteoarthritis through the p38-MAPK/NF-κB signaling pathway, with few adverse reactions.
文章引用:白福贵, 布日古德, 白曙明, 苏力德, 金爱华, 色音宝音, 那阿乐木斯, 韩铁龙, 乌兰巴特尔. 蒙药森登-4汤对p38-MAPK/NF-κB信号通络干预膝关节骨性关节炎的作用机制研究[J]. 临床医学进展, 2025, 15(4): 1088-1096. https://doi.org/10.12677/acm.2025.1541032

参考文献

[1] 国家药典委员会. 中华人民共和国卫生部药品标准: 蒙药分册[M]. 呼和浩特: 内蒙古科学技术出版社, 1998: 184-185.
[2] 许良, 高扬, 刘妍, 包玉敏, 刘景林, 仲丛峰. 蒙药森登-4汤抗炎镇痛有效部位及其化学成分的研究[J]. 时珍国医国药, 2013, 24(1): 1-3.
[3] Forestier, R., Francon, A., Briole, V., Genty, C., Chevalier, X. and Richette, P. (2011) Prevalence of Generalized Osteoarthritis in a Population with Knee Osteoarthritis. Joint Bone Spine, 78, 275-278. [Google Scholar] [CrossRef] [PubMed]
[4] Hedbom, E. and Häuselmann, H.J. (2002) Molecular Aspects of Pathogenesis in Osteoarthritis: The Role of Inflammation. Cellular and Molecular Life Sciences (CMLS), 59, 45-53. [Google Scholar] [CrossRef] [PubMed]
[5] Schulze-Tanzil, G., Zreiqat, H., Sabat, R., Kohl, B., Halder, A., Muller, R., et al. (2009) Interleukin-10 and Articular Cartilage: Experimental Therapeutical Approaches in Cartilage Disorders. Current Gene Therapy, 9, 306-315. [Google Scholar] [CrossRef] [PubMed]
[6] Murphy, G., Knäuper, V., Atkinson, S., Butler, G., English, W., Hutton, M., et al. (2002) Matrix Metalloproteinases in Arthritic Disease. Arthritis Research, 4, S39. [Google Scholar] [CrossRef] [PubMed]
[7] Inada, M., Wang, Y., Byrne, M.H., Rahman, M.U., Miyaura, C., López-Otín, C., et al. (2004) Critical Roles for Collagenase-3 (Mmp13) in Development of Growth Plate Cartilage and in Endochondral Ossification. Proceedings of the National Academy of Sciences of the United States of America, 101, 17192-17197. [Google Scholar] [CrossRef] [PubMed]
[8] Naito, K., Takahashi, M., Kushida, K., Suzuki, M., Ohishi, T., Miura, M., et al. (1999) Measurement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) in Patients with Knee Osteoarthritis: Comparison with Generalized Osteoarthritis. Rheumatology, 38, 510-515. [Google Scholar] [CrossRef] [PubMed]
[9] Knäuper, V., Bailey, L., Worley, J.R., Soloway, P., Patterson, M.L. and Murphy, G. (2002) Cellular Activation of Prommp‐13 by MT1‐MMP Depends on the C‐Terminal Domain of Mmp‐13. FEBS Letters, 532, 127-130. [Google Scholar] [CrossRef] [PubMed]
[10] Konttinen, Y.T., Ainola, M., Valleala, H., Ma, J., Ida, H., Mandelin, J., et al. (1999) Analysis of 16 Different Matrix Metalloproteinases (MMP-1 to MMP-20) in the Synovial Membrane: Different Profiles in Trauma and Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 58, 691-697. [Google Scholar] [CrossRef] [PubMed]
[11] Gilbert, S., Blain, E., Al-Sabah, A., Zhang, Y., Duance, V. and Mason, D. (2012) Protein Kinase R Plays a Pivotal Role in Oncostatin M and Interleukin-1 Signalling in Bovine Articular Cartilage Chondrocytes. European Cells and Materials, 23, 41-57. [Google Scholar] [CrossRef] [PubMed]
[12] Dean, D.D. and Woessner, J.F. (1984) Extracts of Human Articular Cartilage Contain an Inhibitor of Tissue Metalloproteinases. Biochemical Journal, 218, 277-280. [Google Scholar] [CrossRef] [PubMed]
[13] Heard, B.J., Martin, L., Rattner, J.B., Frank, C.B., Hart, D.A. and Krawetz, R. (2012) Matrix Metalloproteinase Protein Expression Profiles Cannot Distinguish between Normal and Early Osteoarthritic Synovial Fluid. BMC Musculoskeletal Disorders, 13, Article No. 126. [Google Scholar] [CrossRef] [PubMed]
[14] Ertenli, I., Kiraz, S. and Calguneri, M. (2001) Synovia I Fluid Cytokine Levels in Behcers Disease. Clinical and Experimental Rheumatology, 19, 37-41.
[15] Kuiper, S., Joosten, L.A.B., Bendele, A.M., Edwards III, C.K., Arntz, O.J., Helsen, M.M.A., et al. (1998) Different Roles of Tumour Necrosis Factor Α and Interleukin 1 in Murine Streptococcal Cell Wall Arthritis. Cytokine, 10, 690-702. [Google Scholar] [CrossRef] [PubMed]
[16] Rai, P., Singh, A., Singh, O., Rai, N. and Dwivedi, A. (2011) Efficacy of Leech Therapy in the Management of Osteoarthritis (Sandhivata). AYU (An International Quarterly Journal of Research in Ayurveda), 32, 213-217. [Google Scholar] [CrossRef] [PubMed]
[17] Xiu, Z.B., Chen, W.T. and Sun, K.M. (2011) Study on Correlation between the Pathological Changes under Arthroscopy and the Cytokine Levels in the Knee Osteoarthritis of the Blood Stasis Type. Chinese Journal of Orthopaedic Trauma, 23, 890-893.
[18] Uchimura, T., Foote, A.T., Smith, E.L., Matzkin, E.G. and Zeng, L. (2015) Insulin‐Like Growth Factor II (IGF‐II) Inhibits Il‐1β‐induced Cartilage Matrix Loss and Promotes Cartilage Integrity in Experimental Osteoarthritis. Journal of Cellular Biochemistry, 116, 2858-2869. [Google Scholar] [CrossRef] [PubMed]
[19] Wojdasiewicz, P., Poniatowski, Ł.A. and Szukiewicz, D. (2014) The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis. Mediators of Inflammation, 2014, Article ID: 561459. [Google Scholar] [CrossRef] [PubMed]
[20] Jung, Y., Kim, G., Park, H., Lee, E., Choi, J., Beier, F., et al. (2013) Role of Interleukin‐10 in Endochondral Bone Formation in Mice: Anabolic Effect via the Bone Morphogenetic Protein/Smad Pathway. Arthritis & Rheumatism, 65, 3153-3164. [Google Scholar] [CrossRef] [PubMed]
[21] Hulejová, H., Barešová, V., Klézl, Z., Polanská, M., Adam, M. and Šenolt, L. (2007) Increased Level of Cytokines and Matrix Metalloproteinases in Osteoarthritic Subchondral Bone. Cytokine, 38, 151-156. [Google Scholar] [CrossRef] [PubMed]
[22] 王友庆. 双醋瑞因/双氯芬酸钠肠溶片治疗膝骨关节炎临床疗效分析[J]. 浙江中医药大学学报, 2013, 37(1): 45-47.
[23] 肖巍, 杜晓红, 李曙波, 等. 膝骨关节炎发病机制及腔内治疗概述[J]. 中国民族民间医药, 2013, 22(3): 47-48.
[24] 董玉, 陈朝军. 蒙药森登-4有效部位化学成分的研究[J]. 内蒙古大学学报, 2009, 40(2): 239-242.
[25] 宋海超, 白埔, 董玉. 蒙药森登-4有效部位化学成分分离与鉴定(II) [J]. 内蒙古大学学报, 2015, 46(1): 71-74.
[26] 白埔, 萨础拉, 董玉. 高效液相色谱法同时测定森登-4有效部位中7种成分的含量[J]. 药物分析杂志, 2016, 36(4): 602-606.
[27] 傅春升, 娄红祥, 张学顺. 栀子的化学成分与药理作用[J]. 现代药物与临床, 2004, 19(4): 152-156.
[28] 金鸣, 臧宝霞, 吴伟, 等. 芦丁拮抗血小板活化因子与受体结合的作用[J]. 中草药, 2005, 36(3): 390-392.
[29] 张莉静, 刘志国, 孟大利, 等. 杨梅树皮提取物及杨梅素抗肿瘤活性[J]. 沈阳药科大学学报, 2009, 26(4): 307-311.
[30] 成帅, 胡振勇, 陈连锁, 等, 膝骨性关节炎患者生活质量及其影响因素研究[J]. 华南预防医学, 2020, 46(2): 159-161.
[31] Belk, J.W., Kraeutler, M.J., Houck, D.A., Goodrich, J.A., Dragoo, J.L. and McCarty, E.C. (2020) Platelet-Rich Plasma versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The American Journal of Sports Medicine, 49, 249-260. [Google Scholar] [CrossRef] [PubMed]
[32] 赵承武. 抵抗素通过CAP1受体激活p38-MAPK/NF-κB信号通路调控膝关节骨性关节炎的作用机制研究[D]: [博士学位论文]. 长春: 吉林大学, 2020.
[33] Soleimani, A., Rahmani, F., Ferns, G.A., Ryzhikov, M., Avan, A. and Hassanian, S.M. (2020) Role of the NF-κB Signaling Pathway in the Pathogenesis of Colorectal Cancer. Gene, 726, Article ID: 144132. [Google Scholar] [CrossRef] [PubMed]
[34] 罗煜, 吴嘉思, 朱正文. 盐酸巴马汀抑制NF-κB/p38-MAPK 信号通路及NLRP3炎症小体抗炎机制研究[J]. 中药新药与临床药理, 2020, 31(7): 762-768.
[35] 方明楚, 林振浪. 氯喹通过抑制F-κB和MAPK信号通路减轻脂多糖诱导的BV2小胶质细胞炎症反应[J]. 中国病理生理杂志, 2020, 36(7): 1320-1326.
[36] 白福贵, 白曙明, 等. 蒙药森登-4汤对膝关节骨性关节炎保护临床应用基础研究[J]. 中国民族医药杂志, 2023, 29(1): 1-3.